Last reviewed · How we verify

NCT01678157: Strattice

Use of Strattice Mesh in Paraesophageal Hernia Surgery

Completed Last updated 6 September 2023
What this trial tests

trial in Esophageal Hernia in 35 participants. Completed in 1 May 2015.

Timeline
5 March 2012
Primary endpoint
1 May 2015
1 May 2015

Quick facts

Lead sponsorUniversity of Nebraska
StatusCompleted
Study typeOBSERVATIONAL
Enrollment35
Start date5 March 2012
Primary completion1 May 2015
Estimated completion1 May 2015
Sites1 location across United States

Conditions studied

Sponsor

University of Nebraska

Who can join

19 and older, any sex, with Esophageal Hernia or Hernia, Esophageal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to examine the safety and efficacy of porcine acellular dermal matrix mesh (Strattice; LifeCell Corp., Branchburg, NJ) in crural reinforcement of laparoscopic large paraesophageal hernia repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Nebraska trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01678157.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing